Every other triple agonist in the pipeline - UBT-251, HM-15275, ASC37, and the Chinese programs - is a potential fast-follower that can compete on price and access rather than on efficacy-above-Retatrutide
What Emerging Research Suggests About the Next Era of Metabolic Science How a Four-Pathway Approach to Metabolism Could Redefine Fat Loss, Muscle Preservation, and the Future of Multi-Agonist Research Disclaimer: The content published under this authors byline is provided for informational and educational purposes only and reflects theoretical research discussions related to peptides, biochemistry, and related scientific topics
If our supplements don't work for you, let us know & we will make it right.*
DY has received consulting or speaker fees from Eli Lilly Japan K.K., Mitsubishi Tanabe Pharma, MSD K.K., Nippon Boehringer Ingelheim, Novo Nordisk Pharma Ltd and Sumitomo Pharma, and clinically commissioned/received joint research grants from Arklay, Nippon Boehringer Ingelheim, Novo Nordisk Pharma Ltd and Taisho Pharmaceutical
Doctronics AI-powered platform provides fast, personalized medical advice drawing on the latest peer-reviewed research
Shortage of Mounjaro (tirzepatide) injections
